These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28272056)

  • 1. Commentary on "The association between sexual function and prostate cancer risk in US veterans".
    Wang K; Cottler LB
    Asian J Androl; 2018; 20(1):99. PubMed ID: 28272056
    [No Abstract]   [Full Text] [Related]  

  • 2. The association between sexual function and prostate cancer risk in US veterans.
    Zapata DF; Howard LE; Frank J; Simon RM; Hoyo C; Grant DJ; Freedland SJ; Vidal AC
    Asian J Androl; 2017; 19(2):191-195. PubMed ID: 27586025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Commentary on "The association between sexual function and prostate cancer risk in US veterans".
    Vidal AC; Freedland SJ
    Asian J Androl; 2018; 20(1):100. PubMed ID: 28272057
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of biochemical recurrence in prostate cancer among US veterans.
    Uchio EM; Aslan M; Wells CK; Calderone J; Concato J
    Arch Intern Med; 2010 Aug; 170(15):1390-5. PubMed ID: 20696967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
    Chamie K; DeVere White RW; Lee D; Ok JH; Ellison LM
    Cancer; 2008 Nov; 113(9):2464-70. PubMed ID: 18666213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 12-core versus 8-core prostate biopsy: multivariate analysis of large series of US veterans.
    Abd TT; Goodman M; Hall J; Ritenour CW; Petros JA; Marshall FF; Issa MM
    Urology; 2011 Mar; 77(3):541-7. PubMed ID: 20817273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Research Implications of Prostate Specific Antigen Registry Errors: Data from the Veterans Health Administration.
    Guo DP; Thomas IC; Mittakanti HR; Shelton JB; Makarov DV; Skolarus TA; Cooperberg MR; Sonn GA; Chung BI; Brooks JD; Leppert JT
    J Urol; 2018 Sep; 200(3):541-548. PubMed ID: 29630980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.
    Loeb S; Byrne N; Makarov DV; Lepor H; Walter D
    JAMA; 2018 Jun; 319(21):2231-2233. PubMed ID: 29800017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer detection in veterans with a history of Agent Orange exposure.
    Zafar MB; Terris MK
    J Urol; 2001 Jul; 166(1):100-3. PubMed ID: 11435832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
    Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
    JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the United States veterans with prostate cancer.
    Jung K; Park JC; Kang H; Brandes JC
    Epidemiol Health; 2018; 40():e2018040. PubMed ID: 30121970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and prostate cancer risk: a case-control study.
    Shannon J; Tewoderos S; Garzotto M; Beer TM; Derenick R; Palma A; Farris PE
    Am J Epidemiol; 2005 Aug; 162(4):318-25. PubMed ID: 16014776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer in US Air Force veterans of the Vietnam war.
    Pavuk M; Michalek JE; Ketchum NS
    J Expo Sci Environ Epidemiol; 2006 Mar; 16(2):184-90. PubMed ID: 16047038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy.
    Issa MM; Zasada W; Ward K; Hall JA; Petros JA; Ritenour CW; Goodman M; Kleinbaum D; Mandel J; Marshall FF
    Cancer Detect Prev; 2006; 30(3):269-75. PubMed ID: 16844319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percentage of tumor in prostatectomy specimens: a study of American Veterans.
    Vollmer RT
    Am J Clin Pathol; 2009 Jan; 131(1):86-91. PubMed ID: 19095570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active surveillance for prostate cancer in a veteran population.
    Lee EK; Baack J; Penn H; Bromfield CT; Duchene DA; Thrasher JB; Holzbeierlein JM
    Can J Urol; 2010 Dec; 17(6):5429-35. PubMed ID: 21172105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer and prostate-specific antigen: facts, figures and commentary.
    Chambers DC
    J Insur Med; 1993; 25(3):336-40. PubMed ID: 10146433
    [No Abstract]   [Full Text] [Related]  

  • 18. Velocity and doubling time of prostate-specific antigen: mathematics can matter.
    Uchio E; Aslan M; Ko J; Wells CK; Radhakrishnan K; Concato J
    J Investig Med; 2016 Feb; 64(2):400-4. PubMed ID: 26767890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary nationwide patterns of self-reported prostate-specific antigen screening in US veterans.
    Pucheril D; Sammon JD; Sood A; Abdollah F; Choueiri TK; Meyer C; Hanske J; Kim SP; Nguyen PL; Kibel AS; Weissman JS; Menon M; Trinh QD
    Urol Oncol; 2015 Dec; 33(12):503.e7-15. PubMed ID: 26319352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of diabetes and positive prostate biopsy in a US veteran population.
    Moses KA; Utuama OA; Goodman M; Issa MM
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):70-4. PubMed ID: 21894176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.